Cancer Treatment Breakthroughs
$24.95
Title | Range | Discount |
---|---|---|
Trade Discount | 5 + | 25% |
- Description
- Additional information
Description
Australia consistently ranks in the top countries in the world for early detection and excellent treatment—they have one of the lowest cancer mortality rates in the world (10% lower than the estimated global average in 2018) and their policy and planning infrastructure within their healthcare system comes out on top globally. Authors Tim and Jackey have combined this information from Australia with studies and reports from around the world including the United States to create a thorough yet easy to understand guide to cancer treatment today.
Internationally renowned experts included in the book:
- Professor David Bowtell, co-Head of the Women’s Cancer Program at the Peter MacCallum Cancer Centre and Principal Investigator for the Australian Ovarian Cancer Study
Professor Jonathan Cebon, Head of the Cancer Immunobiology Program at the Olivia Newton-John Cancer Research Institute
Dr Nils Lonberg, formerly Senior Vice President of Biologics Discovery and Head of Oncology Discovery at Bristol-Myers Squibb and member of the Cancer Immunotherapy Consortium (CIC) Steering Committee.
Professor Steve Ellen, Director, Psychosocial Oncology Program and the Department of Cancer Experiences Research, Peter MacCallum Cancer Centre
Contents About the Authors Prologue Chapter 1 The world's biggest problem It's all about cells Will I get it? Cancer Across the millennia New Approaches Chapter 2 What are we dealing with here? – Advanced diagnostics Catching it early Taking scans nuclear A targeted approach Making it simple Chapter 3 The cutting edge – Surgical techniques Surgery through key hole technology in operation Chapter 4 Turn on the radiotherapy Returning to la dolce vita External radiotherapy Internal radiotherapy Radiosensitisers Chapter 5 Hitting the target – Chemotherapy Eight times lucky A WWII breakthrough 1960s development A targeted approach Chemotherapy and the 'big' cancers Targeted therapies – Angiogenesis inhibitors (ling and bowel cancer) – Anti-epidermal growth factor receptor therapies ( lung, breast and bowel cancer) – Selective estrogen receptor modulators (breast cancer) – Aromatase inhibitors (breast cancer) – Bisphosphonates (breast and prostate cancer) – Anti ADT-resistant drugs (prostate cancer) Overcoming drug-resistant cells Chapter 6 Helping the body to fight back – immunotherapy Bouncing back from a fall Not a new science Stem cell transplants signalling therapies Immune surveillance Regulatory cells Killer T-cells Co-stimulatory molecules and checkpoint inhibitors Chapter 7 Combining the treatments From horror story to happy ending Surgery combinations Chemotherapy combinations Immunotherapy combinations Chapter 8 Making it personal – Personalize medicine Understanding cancer through genetics Decoding the genome Getting the right therapy to the right patient Chapter 9 Eliminating error – Clinical trials 'Lazarus' rising Company-versus investigator-sponsored trials From concept to clinic Who takes part in trials and for how long? How do patients get on to trials? Harnessing advanced technologies in trials More trials mean better results Chapter 10 The human element – Psychosocial oncology Living with melanoma An emotional roller-coaster Challenges across the spectrum A team approach A tailored approach Measuring effectiveness Psychosocial survivorship Chapter 11 Living with cancer A recipe for resilience Eating well Exercising the body Complementary medicine Palliative care Survivorship Managing Pain Cancer risks Chapter 12 How to eat well Good eating – the basics Simple recipes for good eating References
Additional information
Dimensions | 1 × 9 × 6 in |
---|